# José Alvir

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jose-alvir/

## Facts

| Field | Value |
| --- | --- |
| Citations | 6,087 |
| Field | Schizophrenia research and treatment |
| h-index | 32 |
| i10-index | 53 |
| Last Known Institution | Pfizer (United States) |
| OpenAlex ID | https://openalex.org/A5076045633 |
| ORCID iD | 0000-0003-3234-9509 |
| Works | 141 |

## Researcher papers

- [Duration of psychosis and outcome in first-episode schizophrenia](https://scholariq.org/papers/duration-of-psychosis-and-outcome-in-first-episode-schizophrenia/)
- [Longitudinal study of brain morphology in first episode schizophrenia](https://scholariq.org/papers/longitudinal-study-of-brain-morphology-in-first-episode-schizophrenia/)
- [Patient‐reported reasons for discontinuing overactive bladder medication](https://scholariq.org/papers/patient-reported-reasons-for-discontinuing-overactive-bladder-medication/)
- [Observed Classroom Behavior of Children with ADHD: Relationship to Gender and Comorbidity](https://scholariq.org/papers/observed-classroom-behavior-of-children-with-adhd-relationship-to-gender-and/)
- [Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients](https://scholariq.org/papers/gender-differences-in-onset-of-illness-treatment-response-course-and-biologic/)
- [Depression in first-episode schizophrenia](https://scholariq.org/papers/depression-in-first-episode-schizophrenia/)
- [What do we know about quality of life in dementia? A review of the emerging evidence on the predictive and explanatory value of disease specific measures of health related quality of life in people with dementia](https://scholariq.org/papers/what-do-we-know-about-quality-of-life-in-dementia-a-review-of-the-emerging/)
- [A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective](https://scholariq.org/papers/a-structured-literature-review-of-the-burden-of-illness-and-unmet-needs-in/)
- [Absence of regional hemispheric volume asymmetries in first-episode schizophrenia](https://scholariq.org/papers/absence-of-regional-hemispheric-volume-asymmetries-in-first-episode/)
- [Prospective Study of Tardive Dyskinesia in the Elderly: Rates and Risk Factors](https://scholariq.org/papers/prospective-study-of-tardive-dyskinesia-in-the-elderly-rates-and-risk-factors/)
- [A Retrospective Study of Clinical and Economic Burden of Focal Segmental Glomerulosclerosis (FSGS) in the United States](https://scholariq.org/papers/a-retrospective-study-of-clinical-and-economic-burden-of-focal-segmental/)

## Researcher topics

- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [Hemophilia Treatment and Research](https://scholariq.org/topics/hemophilia-treatment-and-research/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Bipolar Disorder and Treatment](https://scholariq.org/topics/bipolar-disorder-and-treatment/)

## Researcher university

- [Pfizer (United States)](https://scholariq.org/institutions/pfizer-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.